Maven Securities »

Immunome shares owned by Maven Securities

Quarter-by-quarter ownership of Immunome (IMNM) shares owned by Maven Securities from 13F filings

Historical chart of Maven Securities investment in Immunome

Tip: Access up to 7 years of quarterly data

All positions including Immunome held by Maven Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunome by Maven Securities

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.6M 75k 21.48

More positions owned by Maven Securities

Spdr S&p 500 Etf Tr Put Put Option
Spdr S&p 500 Etf Tr Call Call Option
Invesco Qqq Tr Call Call Option
Invesco Qqq Tr Put Put Option
Select Sector Spdr Tr Put Put Option
Select Sector Spdr Tr Put Put Option
Apple Put Put Option
Select Sector Spdr Tr Put Put Option
Newmont Corp Put Put Option
Select Sector Spdr Tr Call Call Option
Unitedhealth Group Put Put Option
Nvidia Corporation Put Put Option
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon Call Call Option

View all positions for Maven Securities

Top funds holding Immunome

T. Rowe Price Investment Management
FMR
BlackRock
Point72 Asset Management
Vanguard Group
Redmile Group
Enavate Sciences GP
PRIMECAP Management Company
Leucadia National Corporation
State Street Corporation
EcoR1 Capital
Geode Capital Management
Toronto-Dominion Bank
Readystate Asset Management
Sofinnova Ventures

View all funds holding Immunome